Observations placeholder
Zantac and Ranitidine
Identifier
005562
Type of Spiritual Experience
Background
A description of the experience
Ranitidine - trade name Zantac
Ranitide is a a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). The drug not only increases gastric pH, but also reduces the total output of gastric juice. Ranitidine used to be administered long term for reflux treatment, sometimes indefinitely. It has since largely been superseded by proton pump inhibitors. It was introduced in 1981 and was the world's biggest-selling prescription drug by 1988. Ranitidine is also known to give false positives for methamphetamine on drug tests.
Ranitidine is used alongside fexofenadine and other antihistamines for the treatment of skin conditions such as hives. Certain preparations of ranitidine are available over the counter (OTC) in some countries. Outside the United States and Canada, ranitidine is combined with bismuth (which acts as a mild antibiotic) as a citrate salt (ranitidine bismuth citrate, Tritec), to treat Helicobacter pylori infections. This combination is usually given with clarithromycin, an antibiotic.
On Jan, 28, 2017 40,907 people reported to have side effects when taking Ranitidine. Among them, 215 people (0.53%) have Hallucination
On Feb, 01, 2017 40,907 people reported to have side effects when taking Ranitidine. Among them, 76 people (0.19%) have Hallucination, Auditory
On Feb, 01, 2017 40,907 people reported to have side effects when taking Ranitidine. Among them, 4 people (0.01%) have Hallucination, Gustatory
On Feb, 01, 2017 40,907 people reported to have side effects when taking Ranitidine. Among them, 6 people (0.01%) have Hallucination, Olfactory
On Feb, 01, 2017 40,907 people reported to have side effects when taking Ranitidine. Among them, 8 people (0.02%) have Hallucination, Tactile
On Jan, 27, 2017 46,102 people reported to have side effects when taking Zantac. Among them, 209 people (0.45%) have Hallucination
On Jan, 23, 2017 46,102 people reported to have side effects when taking Zantac. Among them, 84 people (0.18%) have Hallucination, Visual
On Feb, 01, 2017 46,102 people reported to have side effects when taking Zantac. Among them, 73 people (0.16%) have Hallucination, Auditory
Time on Zantac when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 62.50% | 12.50% | 0.00% | 12.50% | 0.00% | 0.00% | 12.50% |
Gender of people who have Hallucination when taking Zantac :
| Female | Male | |
| Hallucination | 56.83% | 43.17% |
Age of people who have Hallucination when taking Zantac :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 4.35% | 2.42% | 1.93% | 9.18% | 16.43% | 16.91% | 48.79% |
Severity of Hallucination when taking Zantac :
| least | moderate | severe | most severe | |
| Hallucination | 0.00% | 50.00% | 50.00% | 0.00% |